Despite challenges for approval and access, regenerative therapies for retinal diseases may not be far away from becoming ...

In this video from the American Academy of Dermatology Annual Meeting, Brian S. Kim, MD, MTR, discusses the expansion of ...

CHICAGO — Alcohol-related cirrhosis carries a twofold higher mortality risk than cirrhosis stemming from metabolic ...

Sharp differences in mortality rates and costs related to alcohol-associated hepatitis before and after the COVID-19 pandemic ...

The 5th Circuit Court of Appeals has temporarily restored a rule the FDA lifted in 2023 that requires mifepristone to be ...

Until biomarkers that can predict treatment response emerge, early and aggressive treatment is recommended in lupus nephritis ...

The AI-assisted colonoscopy era was associated with a 47% reduction in interval colorectal cancer incidence and higher ...

AI highlighted evidence-based research when asked about the safety of acetaminophen use during pregnancy, according to data ...

In this video, Aaron M. Drucker, MD, ScM, FRCPC, FAAD, discusses some of the new molecules coming for atopic dermatitis that ...

CHICAGO —The AI-assisted colonoscopy era was associated with a 47% reduction in interval colorectal cancer incidence and higher adenoma detection rates AI-free procedures, according to a study ...

DESTIN, Fla. — Until biomarkers that can predict treatment response emerge, early and aggressive treatment is recommended in lupus nephritis, according to a presenter at Congress of Clinical ...

The FDA has approved the first proteolysis-targeting chimera for any oncologic indication. Vepdegestrant (Veppanu, Arvinas ...